InsidersTradesSigma
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Discover the detailed record of transactions filed by Hagel Jillian Marie, Directeur de la Technologie. Officer active across 1 company, notably Enveric Biosciences, Inc.. In total, 3 reports have been published. Activity tracked since 13 October 2021. The latest transaction was disclosed on 25 January 2023 (Attribution). Regulator: SEC (Form 4). All data is openly available.
3 of 3 declarations
Jillian Marie Hagel serves as the Chief Technology Officer at Enveric Biosciences, Inc. In this role, she is responsible for leading technological initiatives and innovation within the company. Jillian plays a key role in developing technological solutions that support the strategic goals of the organization. Her technical expertise and strategic vision are essential for the growth and success of Enveric.